Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy-Reference-Cited by-同舟云学术

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy

Published:2023-03 Issue:3 Volume:31 Page:686-700
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Uribe-Herranz Mireia^ORCID,Beghi Silvia,Ruella Marco,Parvathaneni Kalpana,Salaris Silvano,Kostopoulos Nektarios,George Subin S.,Pierini Stefano,Krimitza Elisavet,Costabile Francesca,Ghilardi Guido,Amelsberg Kimberly V.,Lee Yong Gu,Pajarillo Raymone,Markmann Caroline,McGettigan-Croce Bevin,Agarwal Divyansh,Frey Noelle,Lacey Simon F.,Scholler John,Gabunia Khatuna,Wu Gary,Chong Elise,Porter David L.,June Carl H.,Schuster Stephen J.,Bhoj Vijay,Facciabene Andrea^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference58 articles.

1. The intriguing history of cancer immunotherapy;Dobosz;Front. Immunol.,2019

2. A guide to cancer immunotherapy: from T cell basic science to clinical practice;Waldman;Nat. Rev. Immunol.,2020

3. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N. Engl. J. Med.,2018

4. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N. Engl. J. Med.,2017

5. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N. Engl. J. Med.,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer;Proceedings of the National Academy of Sciences;2024-07-24

2. CD5 deletion enhances the antitumor activity of adoptive T cell therapies;Science Immunology;2024-07-19

3. Targeting gut and intratumoral microbiota: a novel strategy to improve therapy resistance in cancer with a focus on urologic tumors;Expert Opinion on Biological Therapy;2024-06-24

4. Refining the relationship between gut microbiota and common hematologic malignancies: insights from a bidirectional Mendelian randomization study;Frontiers in Cellular and Infection Microbiology;2024-06-14

5. Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches;Medical Oncology;2024-06-14